vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»10.15690/vsp.v13i1.918vsp-233Research ArticleОБМЕН ОПЫТОМEXCHANGE OF EXPERIENCEАНТИБИОТИКОАССОЦИИРОВАННАЯ ДИАРЕЯ В КЛИНИЧЕСКОЙ ПРАКТИКЕANTIBIOTIC-ASSOCIATED DIARRHEA IN CLINICAL PRACTICEОсадчукМ. А.OsadchukM. A.

PhD, professor, Head of Polyclinic Department of I.M. Sechenov First Moscow State Medical University

osadchuk.mikhail@yandex.ruСвистуновА. А.SvistunovA. A.osadchuk.mikhail@yandex.ruПервый Московский государственный медицинский университет им. И.М. СеченоваРоссияI.M. Sechenov First Moscow State Medical UniversityRussian Federation201411012014131Вопросы современной педиатрии102108Copyright © Осадчук М.А., Свистунов А.А., 20142014Осадчук М.А., Свистунов А.А.Osadchuk M.A., Svistunov A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/233

В статье систематизированы современные данные по актуальной клинической проблеме — антибиотик-ассоциированной диарее. В возникновении антибиотик-ассоциированной диареи основная роль принадлежит нарушению микробиоценоза и иммунному ответу организма. В терапии этой патологии, наряду с использованием метронидазола и ванкомицина, большое значение придают пробиотикам. Пробиотики играют определенную роль также и в предупреждении рецидива и при профилактике антибиотик-ассоциированной диареи. Комплексный подход к верификации антибиотик-ассоциированной диареи и тактике ведения больных дает возможность значительно уменьшить число и степень тяжести возможных осложнений.

 

антибиотик-ассоциированная диареяантибактериальная терапияпробиотикиantibiotic-associated diarrheaantibiotic treatmentprobioticsReferencesBauer M., Kuijper E., van Dissel J. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin. Microbiol. Infect. 2009; 15: 1067–1079.Bauer M., Kuijper E., van Dissel J. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin. Microbiol. Infect. 2009; 15: 1067–1079.Bauer T.M., Lalvani A., Fehrenbach J. et al. Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospita¬lized adults. JAMA. 2001; 285: 313–319.Bauer T.M., Lalvani A., Fehrenbach J. et al. Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospita¬lized adults. JAMA. 2001; 285: 313–319.Bauer M et al. Clinical and microbiological characteristics of community-onset Clostridium difficile infection in the Netherlands. Clin. Microbiol. Infect. 2009; 15: 1087–1092.Bauer M et al. Clinical and microbiological characteristics of community-onset Clostridium difficile infection in the Netherlands. Clin. Microbiol. Infect. 2009; 15: 1087–1092.Cohen S.H. et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect. Control Hosp. Epidemiol. 2010; 31 (5): 2442–2249.Cohen S.H. et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect. Control Hosp. Epidemiol. 2010; 31 (5): 2442–2249.Clifford L., McDonald et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 2005; 353: 2442–2249.Clifford L., McDonald et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 2005; 353: 2442–2249.Loo V.G. et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 2005; 353: 2433–2441.Loo V.G. et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 2005; 353: 2433–2441.Shul'pekova Yu.O. Antibiotic-associated diarrhea. RMZh = Russian medical journal. 2007; 15 (6): 1–6.Shul'pekova Yu.O. Antibiotic-associated diarrhea. RMZh = Russian medical journal. 2007; 15 (6): 1–6.Shchekina M.I. Role probitikov correction dysbiotic violations. Consilium medicum. Gastroenterologiya = Consilium medicum. Gastroenterology. 2009; 2: 36–42.Shchekina M.I. Role probitikov correction dysbiotic violations. Consilium medicum. Gastroenterologiya = Consilium medicum. Gastroenterology. 2009; 2: 36–42.Rumyantsev V.G. Probiotics: Prospects for therapeutic application in inflammatory bowel disease. Farmateka = Pharmateca. 2009; 13: 77–79.Rumyantsev V.G. Probiotics: Prospects for therapeutic application in inflammatory bowel disease. Farmateka = Pharmateca. 2009; 13: 77–79.Bricker E. et al. Antibiotic treatment for C. difficile-associated diarrhea in adults. Cochr. Database Syst. Rev. 2005; 25 p.Bricker E. et al. Antibiotic treatment for C. difficile-associated diarrhea in adults. Cochr. Database Syst. Rev. 2005; 25 p.Cremonini F. et al. Meta-analysis: the eff ect of probiotic administration on antibioticsso-ciated diarrhea. Aliment. Pharmacol. Ther. 2002; 16: 8.Cremonini F. et al. Meta-analysis: the eff ect of probiotic administration on antibioticsso-ciated diarrhea. Aliment. Pharmacol. Ther. 2002; 16: 8.Lamontagne F., Labbe A.C., Haeck O. et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann. Surg. 2007; 245: 267–272.Lamontagne F., Labbe A.C., Haeck O. et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann. Surg. 2007; 245: 267–272.McFarland L.V. Diarrhea acquired in the hospital. Gastroenterol. Clin. North Am. 1993; 22: 563–577.McFarland L.V. Diarrhea acquired in the hospital. Gastroenterol. Clin. North Am. 1993; 22: 563–577.Zakharenko S.M. Antibiotics and probiotics competitors or synergists? Infektsion. bol. = Infectious diseases. 2007; 5 (1): 47–53.Zakharenko S.M. Antibiotics and probiotics competitors or synergists? Infektsion. bol. = Infectious diseases. 2007; 5 (1): 47–53.Shcherbakov P.L., Nizhevich A.A., Amirova V.R. Antibiotic-associated diarrhea in children - especially correction microflora. Vopr. prakt. pediatrii = Problems of practical pediatrics. 2010; 5 (5): 24–27.Shcherbakov P.L., Nizhevich A.A., Amirova V.R. Antibiotic-associated diarrhea in children - especially correction microflora. Vopr. prakt. pediatrii = Problems of practical pediatrics. 2010; 5 (5): 24–27.Bel'mer S.V. Antibiotic-associated intestinal dysbiosis. RMZh = Russian medical journal. 2004; 12 (3): 148–151.Bel'mer S.V. Antibiotic-associated intestinal dysbiosis. RMZh = Russian medical journal. 2004; 12 (3): 148–151.Simanenkov V., Il'yashevich I., Konovalova N. Probiotic therapy in treatment of pneumonia. Vrach = The doctor. 2010; 3: 46–49.Simanenkov V., Il'yashevich I., Konovalova N. Probiotic therapy in treatment of pneumonia. Vrach = The doctor. 2010; 3: 46–49.Sukhorukova, M.V. .V. Timokhova, M.V. Eidel'shtein, R.S. Kozlov The sensitivity of antibiotic-resistant strains of bacteria belonging to the probiotic "Linex". Klin. mikrobiol. i antimikrob. khimioter. = Clinical microbiology and antimicrobial chemotherapy. 2012; 14 (3): 245–251.Sukhorukova, M.V. .V. Timokhova, M.V. Eidel'shtein, R.S. Kozlov The sensitivity of antibiotic-resistant strains of bacteria belonging to the probiotic "Linex". Klin. mikrobiol. i antimikrob. khimioter. = Clinical microbiology and antimicrobial chemotherapy. 2012; 14 (3): 245–251.Wistrom J., Norrby S.R., Myhre E.B. et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J. Antimicrob. Chemother. 2001; 47: 43–50.Wistrom J., Norrby S.R., Myhre E.B. et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J. Antimicrob. Chemother. 2001; 47: 43–50.Babcock G., Broering T., Hernandez H. et al. Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters. Infect. Immun. 2006; 74: 6339–6347.Babcock G., Broering T., Hernandez H. et al. Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters. Infect. Immun. 2006; 74: 6339–6347.Allen S.J., Wareham K., Wang D. et al. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2013; doi: 10.1016/S0140-6736(13)61218-0.Allen S.J., Wareham K., Wang D. et al. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2013; doi: 10.1016/S0140-6736(13)61218-0.

The authors declare that there are no conflicts of interest present.